MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
311<br />
they so desperately need and deserve and which is afforded to patients with other serious illnesses as a<br />
matter of course.<br />
Carried out by the Wessely School themselves, the MRC PACE Trial, however, is likely to ensure that ‐‐<br />
suicide apart ‐‐ sufferers of <strong>ME</strong>/CFS will be offered only <strong>in</strong>appropriate and potentially harmful<br />
psychotherapy and so will have no option but to cont<strong>in</strong>ue unsupported to endure their ru<strong>in</strong>ed lives.<br />
Neither the UK Government nor the medical / permanent health <strong>in</strong>surance <strong>in</strong>dustry is likely to care.<br />
However, to quote US <strong>ME</strong>/CFS sufferer and advocate John Herd:<br />
“With the advent of the Whittemore‐Peterson Institute’s XMRV research we may be enter<strong>in</strong>g a new and more relevant<br />
era of research for our illness. So will it put the medical fantasies about the illness to rest? What of the likes of Simon<br />
Wessely and Michael Sharpe who have both created and perpetuated those fantasies under the guise of supposed<br />
science? For decades the psychiatric profession has been <strong>in</strong>creas<strong>in</strong>gly try<strong>in</strong>g to elevate itself by portray<strong>in</strong>g<br />
psychiatry as pure science. What happens now that Simon Wessely’s and Michael Sharpe’s theories about<br />
<strong>ME</strong>/CFS are be<strong>in</strong>g scientifically proven to be noth<strong>in</strong>g more than ta<strong>in</strong>ted data conducted and created to<br />
support preconceived flawed theories? What does the psychiatric research sector do now that it is becom<strong>in</strong>g evident<br />
that two of their own have corrupted ‘the science’ so profoundly? Do the psychiatric sector, academic medical sector<br />
and government health sector distance themselves from such corruptions of science? That is usually what happens<br />
when an <strong>in</strong>vestigator is shown to have been generat<strong>in</strong>g corrupted data. Or will (they) rally around to protect their own,<br />
mak<strong>in</strong>g the whole matter more scientifically reprehensible? As we enter this new era of <strong>ME</strong>/CFS research it is not<br />
enough to let the gradual process of science illum<strong>in</strong>ate the contradictory nature of Simon Wessely’s and<br />
Michael Sharpe’s decades‐long campaigns. We advocates must br<strong>in</strong>g the contradictions to the doorsteps of<br />
psychiatric research, academic medical, government health and media sectors. If we do so effectively, we<br />
can open the doors to more needed research <strong>in</strong> the days and months ahead” (Co‐Cure ACT, <strong>ME</strong>D, NOT,<br />
RES: Will dom<strong>in</strong>oes fall? 26 th October 2009).<br />
This will be difficult: eighteen years after the 1992 CIBA Symposium on CFS, members of the Wessely axis<br />
are still promot<strong>in</strong>g their agenda identified <strong>in</strong> the secret MRC document referred to above.<br />
For example, <strong>in</strong> a 2008 paper compar<strong>in</strong>g “chronic fatigue” <strong>in</strong> Brazil and Brita<strong>in</strong>, Cho and Wessely et al could<br />
not have been more explicit: “British patients were more likely to be a member of a self‐help group and to have had<br />
sick leave / sickness benefit because of CFS, variables claimed to predict poor outcome…The greater public and<br />
medical sanction<strong>in</strong>g of CFS/<strong>ME</strong> and the more favourable economic climate <strong>in</strong> the UK may lead to greater<br />
access to sick leave / benefits for patients with chronic fatigue….There is also evidence of an association<br />
between the so‐called ‘secondary ga<strong>in</strong>’ and health outcomes….Therefore, the higher availability of sick<br />
leave / sickness benefit because of CFS <strong>in</strong> the UK may both contribute to and reflect the greater<br />
‘legitimisation’ of chronic fatigue as a medical disorder” (Physical or psychological? A comparative study<br />
of causal attribution for chronic fatigue <strong>in</strong> Brazilian and British primary care patients. Acta Psychiatr Scand<br />
2008:1‐8).<br />
Reid noted how the article reflected the MRC‐funded PACE Trial of CBT and GET as set out <strong>in</strong> the Trial<br />
Protocol that was published <strong>in</strong> BMC Neurology (2007:7:6): “Predictors of outcome: Predictors of a negative<br />
response to treatment found <strong>in</strong> previous studies <strong>in</strong>clude…membership of a self‐help group, be<strong>in</strong>g <strong>in</strong> receipt of a<br />
disability pension, focus<strong>in</strong>g on physical symptoms and pervasive <strong>in</strong>activity” (3,18,19)<br />
(http://www.meactionuk.org.uk/Wessely‐axis.htm ).<br />
There is no mention <strong>in</strong> that paper of on‐go<strong>in</strong>g viral <strong>in</strong>fection but, perhaps expediently, <strong>in</strong> a paper that came<br />
out about the same time as the XMRV news broke, Wessely quietly <strong>in</strong>serts his own new model that allows<br />
for <strong>in</strong>fection as a perpetuat<strong>in</strong>g factor, so the Wessely School goal‐posts may be subtly shift<strong>in</strong>g: “…a model of<br />
the aetiology of CFS can be constructed from a comb<strong>in</strong>ation of pre‐morbid risk, followed by an acute event lead<strong>in</strong>g to<br />
fatigue, and then a pattern of behavioural and biological responses contribut<strong>in</strong>g to a prolonged severe fatigue syndrome.